Our vision is to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics (theranostics).

With our robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high value theranostic intellectual property, we are poised to deliver on the promise of radiopharmaceuticals.


With 50 years of passion and dedication for the future of PET, we have taken bold steps to advance the development of next generation theranostic agents. This is evident in our construction of a brand new Radiopharmaceutical Contract Manufacturing (RCM) facility that exceeds regulatory compliance standards. We partner with pharma and industry partners to develop and advance access to clinically relevant compounds.


We offer a range of PET radiopharmaceuticals to meet your clinical needs. Our production process offers multiple manufacturing runs each day, which allows our customers flexibility when scheduling patient doses.  This ensures that the dose will be delivered when you need it.


We have created a multi-faceted approach designed to strengthen the quality of PET programs and maximize productivity. We put these programs into action through our experienced team by working with your clinical and administrative staff to enhance clinical and business processes. Our measures of practice excellence are important to the integrity of your practice and delivery of care to your patients. 


We are committed to the on-time delivery of high quality radiopharmaceuticals to meet our clients need in diagnosing and treating critical illnesses every day. We take pride in our record of having a 99% cyclotron uptime, allowing us to successfully deliver more than 400,000 doses annually, servicing imaging centers from coast-to-coast.


Dedicated to providing reliable, high quality products and cutting-edge technologies